General Information of the Compound
| Compound ID |
CP0299564
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-cyano-2-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-3-naphthalen-2-ylguanidine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H26N6O
|
||||||||||||||||||
| Molecular Weight |
450.546
|
||||||||||||||||||
| Canonical SMILES |
O[C@@H](CNCCc1ccc(NC(Nc2ccc3ccccc3c2)=NC#N)cc1)c1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H26N6O/c28-19-31-27(33-25-12-9-21-4-1-2-5-22(21)16-25)32-24-10-7-20(8-11-24)13-15-30-18-26(34)23-6-3-14-29-17-23/h1-12,14,16-17,26,30,34H,13,15,18H2,(H2,31,32,33)/t26-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZMALNKNZJJJCCV-SANMLTNESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor